.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 8,338,489

« Back to Dashboard

Claims for Patent: 8,338,489

Title:Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
Abstract: The present disclosure relates the use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas, for example of infantile hemangiomas. The beta blocker may be a non-selective beta-blocker, for example propranolol. The present disclosure provides an alternative to the known compounds, e.g. corticosteroids, interferon or vincristine, generally used for the treatment of hemangiomas.
Inventor(s): Leaute-Labreze; Christine (Le Haillan, FR), Dumas De La Roque; Eric (Villenave d'Ornon, FR), Taieb; Alain (Bordeaux, FR), Thambo; Jean-Beno t (Bordeaux, FR)
Assignee: Universite Victor Segalen--Bordeaux 2 (Bordeaux Cedex, FR)
Application Number:12/599,266
Patent Claims: 1. A method for treating a hemangioma comprising administering a medicament comprising a beta blocker which is propranolol or a pharmaceutically acceptable salt thereof wherein the medicament is administered at a daily dose of less than or equal to 5 mg/kg of body weight of the patient.

2. The method of claim 1, wherein the hemangioma is a capillary hemangioma or capillary infantile hemangioma.

3. The method of claim 1, wherein the medicament is a syrup or an injectable solution.

4. The method of claim 1, wherein the medicament is for oral administration, and is selected from the group consisting of liquid formulations, oral effervescent dosage forms, oral powders, multiparticule systems, and orodispersible dosage forms.

5. The method of claim 4, wherein the medicament for oral administration is a liquid formulation selected from the group consisting of solutions, syrups, suspensions, emulsions, and oral drops.

6. The method of claim 1, wherein the medicament is for buccal or sublingual routes.

7. The method of claim 1, wherein the medicament is for topical-transdermal administration.

8. The method of claim 7, wherein the medicament is for topical administration and is selected from the group consisting of ointments, creams, gels, lotions, patches, and foams.

9. The method of claim 1, wherein the medicament is for nasal administration.

10. The method of claim 1, wherein the medicament is for rectal administration.

11. The method of claim 1, wherein the medicament is for parenteral administration.

12. A method for treating a hemangioma comprising administering to a patient in need thereof a pharmaceutically acceptable and efficient dose of propranolol or a pharmaceutically acceptable salt thereof wherein the dose administered per day is less than or equal to 5 mg/kg of body weight of the patient.

13. The method of claim 12, wherein the dose administered per day is from 1 to 5 mg/kg of body weight of the patient.

14. The method of claim 12, wherein the hemangioma is a capillary hemangioma or capillary infantile hemangioma.

15. The method of claim 12, wherein the medicament is a syrup or an injectable solution.

16. The method of claim 12, wherein the medicament is for oral administration, and is selected from the group consisting of liquid formulations, oral effervescent dosage forms, oral powders, multiparticule systems, and orodispersible dosage forms.

17. The method of claim 16, wherein the medicament for oral administration is a liquid formulation selected from the group consisting of solutions, syrups, suspensions, emulsions, and oral drops.

18. The method of claim 12, wherein the medicament is for buccal or sublingual routes.

19. The method of claim 12, wherein the medicament is for topical-transdermal administration.

20. The method of claim 19, wherein the medicament is for topical administration and is selected from the group consisting of ointments, creams, gels, lotions, patches, and foams.

21. The method of claim 12, wherein the medicament is for nasal administration.

22. The method of claim 12, wherein the medicament is for rectal administration.

23. The method of claim 12, wherein the medicament is for parenteral administration.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc